May 24, 2018
1 min read
Save

Top stories in hematology/oncology: early esophagogastric cancer detection, US cancer deaths continue to decline

Among the top stories in hematology/oncology is new research showing a breath analysis was able to detect early-stage esophagogastric cancer with good sensitivity and specificity. The downward trend in cancer deaths in the United States continues. Other stories include a meta-analysis showing the benefit from immune checkpoint inhibitors for advanced cancer appeared to be sex-dependent, increased follow-up testing for colorectal cancer did not improve time to recurrence or survival, and remote monitoring via mobile app and sensor technology for patients with head and neck cancer resulted in less severe symptoms than weekly doctor visits.

Breath analysis test shows strong accuracy for detecting esophagogastric cancer

A breath analysis test showed good sensitivity and specificity in detecting early-stage esophagogastric cancer, according to researchers in the U.K. Read More.

US cancer deaths continue to decline

Cancer deaths continue to decline among men, women and children in the United States, according to a collaborative report between the CDC, NCI, American Cancer Society and North American Association of Central Cancer Registries. Read More.

Patients’ sex may impact efficacy of immune checkpoint inhibitors

The magnitude of benefit from immune checkpoint inhibitors for advanced cancer appeared sex-dependent, with women experiencing less benefit, according to results from a meta-analysis. Read More.

Frequent colorectal cancer follow-up does not improve recurrence, survival

More frequent follow-up testing for patients with colorectal cancer did not improve time to recurrence or survival, according to two studies published in JAMA. Read More.

Monitoring tool lowers symptom severity for head, neck cancer

Patients with head and neck cancer who underwent remote monitoring by a mobile app and sensor technology had less severe symptoms than patients who had weekly doctor visits, according to a study scheduled for presentation at the ASCO Annual Meeting. Read More.